FDA Import Refusal J37-0009050-2/131/1C — Danapha Pharmaceutical Joint-Stock Company
The FDA refused shipment J37-0009050-2/131/1C from Danapha Pharmaceutical Joint-Stock Company (Vietnam) on May 24, 2017. The refused product falls under Drugs and Biologics — XYLOMETAZOLINE HCL (ADRENERGIC). Cited charges: 118,16,3280,472
Refusal details
- Date
- May 24, 2017
- Country
- Vietnam
- Product Category
- Drugs and Biologics
- Product Code
- 60CCL53 XYLOMETAZOLINE HCL (ADRENERGIC)
- Charges
- 118,16,3280,472